Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q1 2014 · 10-Q
Revenue$9.29K$9.29K−35.3% vs Q1 2013 Net Income-$1.02M-$1.02MN/M vs Q1 2013 EPS Diluted-$0.01-$0.01N/M vs Q1 2013 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flow-$556,564N/M Margins · derivedGross margin72.8%+15.9 pt vs Q1 2013
Operating margin-8258.3%−3782.9 pt vs Q1 2013
Net margin-10976.5%−6483.7 pt vs Q1 2013
ended Mar 31, 2014 · filed May 15, 2014 · 45 d after period end